Rates of Clostridium difficile infection (CDI) have been on the rise in recent years and this diagnosis can result in significant costs for both individuals and the healthcare system as a whole. Given the recent updated guidelines for CDI, combined with several new agents emerging for this disease, it is critical for healthcare professionals to be aware of the most current research and recommendations for the management of CDI.
RMEI, LLC and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture titled "Clostridium difficile Infection: Emerging Therapies and Recurrence Prevention" which is certified for physicians, pharmacists and nurses. This activity is supported by an educational grant from Optimer.
Dale Gerding, MD, FACP, FIDSA, professor of medicine at the Stritch School of Medicine at Loyola University Chicago, will serve as moderator for this virtual lecture which was derived from a live symposium held in Boston in October 2011.
Healthcare professionals can visit http://www.rmei.com/ to access this activity.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.